Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study ID
- NCT06871579
- Status
- Recruiting
Conditions
- Helicobacter Pylori
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- EnteroTracker(R) EST — DIAGNOSTIC_TESTThe device consists of a gelatin-coated capsule with a collection string wrapped inside.
Study Details
Background: Helicobacter pylori is a bacterium that infects the lining of the stomach and intestines. It can cause peptic ulcers, cancers, and infections. Current methods of diagnosing H. pylori infections have limitations. Researchers want to test a new method of testing for H. pylori. Objective: To compare the esophageal string test (EST) to standard tests for detecting H. pylori infection. Eligibility: People aged 18 years or older with persistent H. pylori infection. Design: Participants will have 3 or 4 clinic visits over 2 to 4 months. Screening visit: Participants will have a physical exam. They will provide a stool sample. Baseline visit: Participants will have blood tests. Then they will have the EST: One end of a string will be taped to the outside of their cheek; the other end will be packed into a capsule. Participants will swallow the capsule, and the string will unwind down their throat into their stomach. The string will be left in for at least 1 hour. Then researchers will gently pull out the string. The fluids soaked into the string will be studied. Some participants will be prescribed antibiotics. Follow-up visit 1: Participants whose H. pylori infection was cured by the antibiotics may leave the study. Those who are still infected will have an endoscopy: A flexible tube will be inserted down the throat and into the stomach. It will take tissue samples from the stomach lining. These participants will then receive antibiotics again. Follow-up visit 2: The physical exam, blood test, and stool sample will be repeated. ...
Key Dates
- Start date
- Jun 11, 2025
- Status verified
- May 2026
- Primary completion
- Jan 30, 2027
- Completion
- Jan 30, 2027
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: EnteroTracker(R) ESTEsophageal string test device consists of a gelatin-coated capsule with a collection string wrapped inside.
Primary Outcome Measure
Proportion of the study population identified positive for H. pylori in EST eluates by PCR. [ Time Frame: Baseline ]
Central Contacts
- Michelle M Luera(240) 236-9276
- Amy D Klion, M.D.(240) 381-6073
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 |
Find similar trials in Bethesda, MD
Related Studies
- PyloPlus Urea Breath Test System Pediatric Safety and Efficacy StudyPHASE3 · Recruiting · ARJ Medical, Inc. · Doral, Florida
- H. Pylori Eradication With Argon Plasma During EndoscopyRecruiting · Christopher C. Thompson, MD, MSc · Boston, Massachusetts
- Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among VeteransPHASE3 · Not Yet Recruiting · VA Office of Research and Development · San Diego, California